Daniel S. Bandari, Bandari, MD

Director
MS Center of California & Research Group
Newport Beach, California

Director, MS Center of California and Research Group

Presentation(s):

• Adherence to OnabotulinumtoxinA Treatment in Post-Stroke and Multiple Sclerosis Patients with Spasticity from the ASPIRE Study

  Thursday, October 22, 2020
  3:30 PM – 3:47 PM EST